A Comparison of Patient Adherence and Preference of Packaging Method for Oral Anticancer Agents Using Conventional Pill Bottles versus Daily Pill Boxes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN74558413

Enrollment

Registered

2005-11-15

Start date

2005-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumors Cancer Solid tumours

Interventions

Daily pill boxes versus conventional pill bottles for packaging

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients were included in this study if they: 1. Provided informed consent 2. Were capable of reading and writing in English 3. Were greater than 18 years of age with solid tumors 4. Were planned to receive at least 2 consecutive cycles of capecitabine

Exclusion criteria

Exclusion criteria: Patients taking other oral anticancer medications such as temozolomide, tamoxifen and arimidex, were not felt to be suitable for the present study since these oral medications are already dispensed in unit dose packages.

Design outcomes

Primary

Measure	Time frame
Patient adherence was similiar.	—

Secondary

Measure	Time frame
Patients more satisfied with daily pill boxes than conventional pill bottles.	—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026